Insider filing · SPRY

Brent L Saunders sold $1.7M of ARS Pharmaceuticals (SPRY)

Executed May 20 2025, disclosed May 22 2025, 2 days later.

Returns are measured on stock purchases only.

BS Brent L Saunders Director profile →

Brent L Saunders (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Bausch + Lomb Corporation (BLCO). Across 1 priced purchase filing, the average 21-session return was -5.0% from execution and -3.3% from disclosure (delay-adjusted; derived). The largest single filing was $252K of BLCO (14,700 sh × $17.14, as filed), executed Mar 6.

SPRY SPRY SPRY · 38 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→